Medical-technology companies are helping revive initial public offerings in the life-sciences sector in the US after a tough year so far, during which regulatory uncertainty has hampered such activity.
Shoulder Innovations Inc., a commercial-stage shoulder surgery implant maker, is on track to price an IPO raising as much as $105 million late Wednesday. That makes it the second medical-devices company to go public in a week, following the debut of spinal-surgery implant market Carlsmed Inc. last Wednesday. Shoulder’s offering has attracted demand for multiple times the available shares, including sizable anchor orders from mutual funds, Bloomberg reported earlier on Tuesday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.